Identification |
Name: | 2H-Naphth[1,2-b]-1,4-oxazin-9-ol,3,4,4a,5,6,10b-hexahydro-4-propyl-, hydrochloride (1:1), (4aR,10bR)- |
Synonyms: | 2H-Naphth[1,2-b]-1,4-oxazin-9-ol,3,4,4a,5,6,10b-hexahydro-4-propyl-, hydrochloride, (4aR,10bR)- (9CI);2H-Naphth[1,2-b]-1,4-oxazin-9-ol, 3,4,4a,5,6,10b-hexahydro-4-propyl-,hydrochloride, (4aR-trans)-; L 647339; MK 458; Naxagolide hydrochloride |
CAS: | 99705-65-4 |
Molecular Formula: | C15H21 N O2 . Cl H |
Molecular Weight: | 0 |
InChI: | InChI=1/C15H21NO2.ClH/c1-2-7-16-8-9-18-15-13-10-12(17)5-3-11(13)4-6-14(15)16;/h3,5,10,14-15,17H,2,4,6-9H2,1H3;1H/t14-,15-;/m1./s1 |
Molecular Structure: |
|
Properties |
Flash Point: | 190.7°C |
Boiling Point: | 391.7°Cat760mmHg |
Density: | 1.109g/cm3 |
Flash Point: | 190.7°C |
Usage: | A dopamine D2-receptor agonist. Used for treatment of extrapyramidal disorders. Antiparkinsonian drug |
Safety Data |
|
|